Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Data Page
  • Published:

Trends in biotech literature 2009

Nature Biotechnology volume 28, page 887 (2010)Cite this article

Subjects

Access through your institution
Buy or subscribe

Proteomics, small RNA-related and stem cell research continue their rapid growth in the literature, with epigenetics and systems biology showing recent expansion. The past decade has witnessed a boom in biotech publications from Asian countries, except for Japan, with Chinese authors now publishing more papers in the area than their US peers but accruing fewer citations.

Historic trends in biotech fields

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Wayne Peng is Emerging Technology Analyst, Nature Publishing Group,

    Wayne Peng

Authors
  1. Wayne Peng
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peng, W. Trends in biotech literature 2009. Nat Biotechnol 28, 887 (2010). https://doi.org/10.1038/nbt0910-887

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0910-887

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research